NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 30 04:00PM ET
155.95
Dollar change
-0.22
Percentage change
-0.14
%
IndexS&P 500 P/E28.00 EPS (ttm)5.57 Insider Own0.10% Shs Outstand446.04M Perf Week-0.88%
Market Cap69.43B Forward P/E22.86 EPS next Y6.82 Insider Trans-0.65% Shs Float444.77M Perf Month-6.69%
Enterprise Value74.46B PEG3.44 EPS next Q1.62 Inst Own96.02% Short Float1.95% Perf Quarter-4.39%
Income2.52B P/S7.48 EPS this Y5.38% Inst Trans0.41% Short Ratio2.86 Perf Half Y-5.31%
Sales9.29B P/B14.94 EPS next Y9.35% ROA17.70% Short Interest8.69M Perf YTD-4.28%
Book/sh10.44 P/C40.34 EPS next 5Y8.13% ROE51.85% 52W High200.33 -22.15% Perf Year-8.75%
Cash/sh3.87 P/FCF30.44 EPS past 3/5Y8.55% 11.91% ROIC25.04% 52W Low139.70 11.63% Perf 3Y-7.81%
Dividend Est.1.99 (1.28%) EV/EBITDA18.96 Sales past 3/5Y5.98% 8.14% Gross Margin69.48% Volatility1.82% 2.03% Perf 5Y12.92%
Dividend TTM1.86 (1.20%) EV/Sales8.02 EPS Y/Y TTM7.23% Oper. Margin37.01% ATR (14)3.53 Perf 10Y210.53%
Dividend Ex-DateJul 18, 2025 Quick Ratio1.04 Sales Y/Y TTM6.32% Profit Margin27.12% RSI (14)39.51 Recom1.58
Dividend Gr. 3/5Y18.93% 21.14% Current Ratio1.74 EPS Q/Q7.88% SMA20-4.23% Beta0.92 Target Price199.92
Payout32.86% Debt/Eq1.45 Sales Q/Q1.37% SMA50-2.58% Rel Volume0.93 Prev Close156.17
Employees13800 LT Debt/Eq1.16 EarningsMay 06 BMO SMA200-8.16% Avg Volume3.04M Price155.95
IPOFeb 01, 2013 Option/ShortYes / Yes EPS/Sales Surpr.5.00% 1.37% Trades Volume2,814,847 Change-0.14%
Date Action Analyst Rating Change Price Target Change
Jun-18-25Downgrade Stifel Buy → Hold $160
Dec-02-24Initiated Leerink Partners Outperform $215
Jul-25-24Initiated BTIG Research Buy $220
Jan-12-24Reiterated Stifel Buy $195 → $215
Dec-19-23Resumed Jefferies Buy $230
Dec-07-23Initiated Exane BNP Paribas Outperform $237
Sep-06-23Initiated HSBC Securities Buy $230
Jul-12-22Initiated Piper Sandler Overweight $205
Nov-18-21Initiated Morgan Stanley Overweight $40
Nov-18-21Initiated Morgan Stanley Overweight $264
Jun-27-25 09:30AM
Jun-26-25 06:02PM
09:03AM
Jun-25-25 01:00PM
Jun-20-25 11:40AM
11:40AM Loading…
11:40AM
11:40AM
11:40AM
Jun-19-25 01:30PM
09:45AM
Jun-18-25 06:15PM
04:56PM
12:46PM
11:50AM
09:18AM
09:50AM Loading…
Jun-16-25 09:50AM
Jun-12-25 06:15PM
08:30AM
Jun-11-25 09:45AM
05:00AM
Jun-06-25 11:31AM
Jun-05-25 01:03PM
11:31AM
09:00AM
08:30AM
Jun-04-25 11:40AM
Jun-02-25 01:30PM
Jun-01-25 04:14AM
May-30-25 09:50AM
01:06AM
08:30AM Loading…
May-27-25 08:30AM
May-26-25 09:45AM
May-23-25 06:30AM
May-22-25 04:15PM
May-21-25 04:15PM
02:14PM
12:00PM
May-20-25 08:35PM
May-19-25 08:58AM
May-16-25 09:55AM
May-15-25 08:30AM
May-12-25 09:50AM
06:20AM
May-09-25 01:46PM
09:45AM
07:26AM
03:25AM
May-08-25 07:04PM
May-07-25 03:08AM
12:07AM
May-06-25 10:03PM
06:33PM
11:07AM
09:30AM
08:10AM
07:08AM
07:00AM
May-04-25 08:53AM
07:42AM
May-03-25 10:39PM
11:00AM
May-02-25 12:43AM
May-01-25 11:40AM
09:15AM
Apr-30-25 06:15PM
10:01AM
Apr-29-25 10:01AM
Apr-28-25 09:04AM
Apr-26-25 06:05PM
02:32PM
Apr-24-25 06:15PM
Apr-23-25 01:32PM
09:10AM
08:40AM
Apr-19-25 10:40AM
08:30AM
Apr-12-25 01:27AM
Apr-08-25 06:32PM
09:47AM
Apr-04-25 09:25AM
Apr-03-25 11:28PM
08:45AM
Apr-02-25 02:12AM
Apr-01-25 11:32AM
Mar-28-25 06:15PM
11:30AM
Mar-27-25 10:00AM
09:38AM
08:30AM
Mar-26-25 10:58AM
Mar-25-25 07:30AM
Mar-21-25 06:15PM
11:30AM
Mar-20-25 02:11PM
09:05AM
06:40AM
Mar-18-25 05:01AM
Mar-14-25 05:01AM
Mar-13-25 06:15PM
Mar-12-25 02:28PM
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments. The company was founded in 1952 and is headquartered in Parsippany, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lagano RoxanneExecutive Vice PresidentJun 03 '25Sale170.00652110,84015,129Jun 04 04:31 PM
Lagano RoxanneOfficerJun 03 '25Proposed Sale170.00652110,840Jun 03 04:22 PM
Reed Willie MDirectorMar 11 '25Proposed Sale166.141,210201,029Mar 11 04:27 PM
Lagano RoxanneExecutive Vice PresidentMar 10 '25Sale170.0032655,42015,781Mar 11 04:20 PM
Reed Willie MDirectorMar 11 '25Sale166.141,210201,02911,245Mar 11 04:20 PM
Lagano RoxanneOfficerMar 10 '25Proposed Sale170.0032655,420Mar 10 05:17 PM
PECK KRISTIN CChief Executive OfficerFeb 19 '25Option Exercise46.0938217,60694,576Feb 20 04:07 PM
PECK KRISTIN CChief Executive OfficerFeb 19 '25Sale156.6838259,85294,194Feb 20 04:07 PM
PECK KRISTIN COfficerFeb 19 '25Proposed Sale156.6838259,852Feb 19 05:18 PM
Lagano RoxanneExecutive Vice PresidentFeb 11 '25Sale171.1832655,80516,107Feb 11 05:15 PM
Lagano RoxanneOfficerFeb 11 '25Proposed Sale171.1832655,805Feb 11 04:33 PM
Polzer Robert JExecutive Vice PresidentNov 25 '24Option Exercise161.633,477561,9856,726Nov 26 04:27 PM
Polzer Robert JExecutive Vice PresidentNov 25 '24Sale177.463,477617,0283,249Nov 26 04:27 PM
Polzer Robert JOfficerNov 25 '24Proposed Sale177.463,477617,029Nov 25 04:20 PM